The global nasal drug delivery market was valued at USD 42.39 billion in 2018 and is projected to reach USD 120.83 billion by 2032, registering a CAGR of 7.9% over the forecast period. In 2018, Europe held the largest share of the market, accounting for 49.82% of the global revenue.
